See today's BioWorld MedTech
To read the full article sign up for free or sign in.

FDA gives thumbs up to Synergy for HBR indication

Aug. 12, 2020
By Liz Hollis
Boston Scientific Corp. has received the U.S. FDA’s nod for a high bleeding risk (HBR) indication for the Synergy drug-eluting stent system.
BioWorld MedTech Clinical Regulatory Cardiovascular Drug eluting stent FDA